  Currently , there are no reliable biomarkers available that can aid early differential diagnosis of reactive arthritis<disease> ( ReA) from other inflammatory joint diseases. Metabolic profiling of synovial fluid ( SF)- obtained from joints affected in ReA-holds great promise in this regard and will further aid monitoring treatment and improving our understanding about disease mechanism. As a first step in this direction , we report here the metabolite specific assignment of